Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.2B | 9.7B | 3.5B | 3.2B |
Cost of revenue | 2.2B | 6.7B | 1.9B | 3.2B |
Gross profit | 2.0B | 3.0B | 1.6B | 22.2M |
Operating expense | ||||
Research & development | — | 931.6M | — | — |
Selling general and admin | 3.4B | 638.2M | 2.6B | 2.6B |
Other operating expenses | — | -464.1M | — | — |
Operating income | 2.0B | 1.0B | -1.0B | -2.5B |
Non operating interest income | ||||
Income | — | 784.6M | — | — |
Expense | — | 2.9M | — | — |
Other income expense | — | — | — | — |
Pretax income | -651.2M | 2.8B | -478.8M | -1.6B |
Tax provision | 74.8M | -431.3M | — | -344.6M |
Net income | -726.0M | 3.2B | -478.8M | -1.2B |
Basic EPS | -37.4 | — | -25 | -63 |
Diluted EPS | -37.4 | — | -25 | -63 |
Basic average shares | — | — | 19.2M | 19.5M |
Diluted average shares | — | — | 19.2M | 19.5M |
EBITDA | 2.0B | 3.1B | -792.3M | -2.3B |
Net income from continuing op. | — | 3.2B | -478.8M | -1.2B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |